RachelP(Greenberger)RosovskyMD
Hematology • Boston, MAClotting Disorder
Attending Physician, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical School
Dr. Rosovsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St Yaw 7
Boston, MA 02114Phone+1 617-726-8743Fax+1 617-726-2001
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2004 - 2007- Brigham and Women's HospitalResidency, Internal Medicine, 2000 - 2003
Harvard Medical SchoolClass of 2000
Certifications & Licensure
MA State Medical License 2003 - 2026- American Board of Internal Medicine Hematology
Clinical Trials
- A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC) Start of enrollment: 2008 Jul 01
- Cancer Associated Thrombosis and Isoquercetin (CATIQ) Start of enrollment: 2015 Jan 01
- Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study) Start of enrollment: 2018 Jul 25
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsCirculating cellular clusters are associated with thrombotic complications and clinical outcomes in COVID-19.Ander Dorken-Gallastegi, Yao Lee, Guansheng Li, He Li, Leon Naar
Iscience. 2023-07-21 - 33 citationsNCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022.Elizabeth A Griffiths, Vivek Roy, Laura Alwan, Kimo Bachiashvili, John Baird
Journal of the National Comprehensive Cancer Network. 2022-05-01 - 1212 citationsClinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein
Lancet. 2020-06-20
Journal Articles
- Multicenter Implementation of a Novel Management Protocol Increases the Outpatient Treatment of Pulmonary Embolism and Deep Vein ThrombosisJean Connors, Christopher Baugh, Christopher Kabrhel, Rachel Rosovsky, Benjamin White, Academic emergency medicine
- Treatment of Submassive and Massive Pulmonary Embolism: A Clinical Practice Survey from the Second Annual Meeting of the Pulmonary Embolism Response Team ConsortiumKenneth Rosenfield, Geoffrey D Barnes, Michael R Jaff, Thomas M Todoran, Christopher Kabrhel, Rachel P Rosovsky, Jay Giri, Journal of Thrombosis and Thrombolysis
Abstracts/Posters
- Urban-Rural Variation in Use of Thrombolytic Therapy for Pulmonary EmbolismRachel P Rosovsky, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Sex Differences in Risk Factors, Clinical Presentation, Treatment and Outcomes of Patients Presenting with Acute Pulmonary Embolism61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- VTE Challenges: A Case-Based Panel Discussion2019 ACP Internal Medicine Meeting, Philadelphia - 4/13/2019
Press Mentions
Get Out the Clot Campaign Brings Together Leaders and Experts to Improve Patient Care for Venous ThromboembolismOctober 10th, 2024- Clinical Decision Support Significantly Reduces Volume of CT Pulmonary Angiogram RequestsAugust 13th, 2024
- Anxiety and Depression Raise the Risk of Dangerous Blood Clots, Study FindsJuly 25th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
- Pulmonary Embolism Response Team (PERT) ConsortiumPresident
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
